Patent application number | Description | Published |
20080241100 | PHARMACEUTICAL COMPOSITION COMPRISING A CYTOKINE - The present invention relates to a pharmaceutical composition comprising, (i) a cytokine and, (ii) a compound of the general formula (Ih) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof. Exemplary cytokines are selected from the following group of cytokine families, (i) the four α-helix bundle family, which consists of, (a) the IL-2 subfamily, (b) the interferon (IFN) subfamily and, (c) the IL-10 subfamily, (ii) the IL-1 family, (iii) the IL-17 family and, (iv) chemokines. | 10-02-2008 |
20110052532 | Pharmaceutical composition comprising a cytokine - The present invention relates to a pharmaceutical composition comprising, (i) a cytokine and, (ii) a compound of the general formula (Ih) or pharmaceutically acceptable salts thereof with an acid or a base, or pharmaceutically acceptable prodrugs or a stereoisomer thereof. Exemplary cytokines are selected from the following group of cytokine families, (i) the four α-helix bundle family, which consists of, (a) the IL-2 subfamily, (b) the interferon (IFN) subfamily and, (c) the IL-10 subfamily, (ii) the IL-1 family, (iii) the IL-17 family and, (iv) chemokines. | 03-03-2011 |
Patent application number | Description | Published |
20090176716 | INHIBITORS OF CANCER CELL, T-CELL AND KERATINOCYTE PROLIFERATION - The invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, | 07-09-2009 |
20090304632 | HETEROCYCLIC NF-kB INHIBITORS - The present invention relates to compounds of the general formula (Ihb) or pharmaceutically acceptable salts thereof with an acid or a base or a stereoisomer thereof for the prevention and/or treatment of a disease associated with increased cytokine release, | 12-10-2009 |
20100280081 | ANTI-INFLAMMATORY AGENTS AS VIROSTATIC COMPOUNDS - The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, | 11-04-2010 |
20110263486 | Inhibitors of Cancer Cell, T-Cell and Keratinocyte Proliferation - The invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, | 10-27-2011 |
20120028985 | COMBINATIONAL THERAPY FOR TREATING AUTOIMMUNE DISEASE - The present invention relates to the treatment and prevention of immunological and inflammatory disorders with a compound of formula (I) in combination with methotrexate, | 02-02-2012 |
20120029034 | Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents - The present invention relates to calcium salts of compounds of the general formula (I) | 02-02-2012 |
20120035175 | Novel salts as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents - The present invention relates to a salt selected from the group comprising the N-methyl-D-glucamine salt (NMG), the diethylamine salt (DEA) salt, the magnesium salt, the tromethamine salt, the choline salt, the L-arginine salt, the zinc salt, and the 4-(2-hydroxyethyl)morpholine (HEM) salt of compounds of the general formula (I) | 02-09-2012 |
20120196861 | IL17 AND IFN-GAMMA INHIBITION FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATION - The present invention relates to compounds of the general formula (I), and the pharmaceutically acceptable salt or solvate thereof, as anti-inflammatory and immunomodulatory agents. | 08-02-2012 |
20120196862 | IL17 AND IFN-GAMMA INHIBITION FOR THE TREATMENT OF AUTOIMMUNE INFLAMMATION - The present invention relates to compounds of the general formula (I), and the pharmaceutically acceptable salt or solvate thereof, as anti-inflammatory and immunomodulatory agents. | 08-02-2012 |
Patent application number | Description | Published |
20100004258 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates to compounds of the general formula (III): | 01-07-2010 |
20100048574 | NOVEL HETEROCYCLIC NF-kB INHIBITORS - The present invention relates to compounds of the general formula (II): | 02-25-2010 |
20100048583 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, | 02-25-2010 |
20100267717 | Novel Heterocyclic NF-kB Inhibitors - The present invention relates in one embodiment to compounds of formula (Ih) and/or a pharmaceutically acceptable salt thereof with an acid or a base, and/or a pharmaceutically acceptable prodrug and/or a stereoisomer thereof, | 10-21-2010 |
20120022068 | NOVEL HETEROCYCLIC NF-kB INHIBITORS - The present invention relates in one embodiment to compounds of formula (Ih) and/or a pharmaceutically acceptable salt thereof with an acid or a base, and/or a pharmaceutically acceptable prodrug and/or a stereoisomer thereof, | 01-26-2012 |